$PHG

Royal Philips announced that two of its AI-enabled healthcare innovation projects, SYMPHONY and AI FORSchung, won ITEA Awards of Excellence 2026. SYMPHONY connects healthcare data and clinical workflows, while AI FORSchung focuses on AI-driven fiber-optic sensing data analysis. The awards were presented at the ITEA PO Days 2026 in Istanbul, Turkey. Philips is a global leader in health technology, listed on NYSE (PHG) and AEX (PHIA).

Dutch exports to the US dropped 25% to €13B in H1 2024, due to 15% tariffs imposed by the Trump administration. Machinery, chemicals, and medical instruments saw significant declines. The US fell from the top five Dutch export destinations. Imports from the US rose 19%, driven by oil prices. Dutch companies are reclaiming €1B in duties, including €186M for Philips.

Philips (NYSE:PHG, AEX: PHIA) launched the Lumea IPL 9900 Pro, an at-home hair removal device with audio guidance and motion tracking. The FDA-cleared device is priced at $699.95 and claims over 90% hair reduction after three treatments. Philips reported 2025 sales of EUR 18 billion.

Royal Philips introduced the eV14-2v transvaginal transducer, FDA-cleared and CE-marked, enhancing its ultrasound portfolio. The transducer offers improved image quality, penetration, and a lighter design, supporting various gynecology and early obstetrics exams. Philips showcased the product at the ISUOG World Congress, highlighting its commitment to women's health technology.

Philips (NYSE: PHG) presented preliminary clinical data supporting its AI-powered 3D Auto Color Flow Quantification (CFQ) technology for measuring mitral regurgitation. The study, shared at the European Society of Cardiology Congress, suggests the technology may improve assessment and monitoring of the condition. Philips claims its approach offers more accurate measurements than traditional methods, potentially aiding faster clinical decisions.

Philips submitted an LED bulb to the DOE's L Prize contest, aiming to replace 60-watt incandescent bulbs. The bulb uses 10 watts, lasts 25,000 hours, and meets U.S. manufacturing requirements. The DOE hopes to reduce carbon emissions by 5.6 million metric tons annually if all 60-watt bulbs were replaced with LEDs. The winner receives $10 million. Philips' bulb is expected to launch in about a year, with utility companies potentially subsidizing costs.

Cl0p ransomware group exploited a vulnerability in PTC's Windchill and FlexPLM software, affecting companies like Shell, Philips, General Electric, and Fiserv. The flaw, CVE-2026-12569, allows unauthenticated remote code execution, leading to the theft of engineering data. PTC patched the issue in June 2026, but exploitation continued. The campaign highlights a shift in Cl0p's tactics, focusing on industrial espionage rather than traditional ransomware attacks.

Philips and Imricor launched a cardiac interventional MR lab solution, combining Philips' 1.5T MRI platform with Imricor's MR-compatible systems. The solution aims to enhance cardiac ablation procedures with MRI-guided precision, reducing radiation exposure. Philips (NYSE: PHG) sees this as a step in advancing MRI across the care continuum, while Imricor (ASX: IMR) highlights the collaboration's shared vision.

Royal Philips and Imricor Medical Systems launched a cardiac interventional MR lab solution, combining Philips' 1.5T MRI platform with Imricor's MR-compatible systems. The solution aims to enhance cardiac intervention procedures by providing detailed tissue visualization without radiation. It is commercially available in CE-marked markets and some U.S. configurations, with further U.S. availability pending regulatory clearances.

Philips (PHG, PHIA) received a $33.7M award from ARPA-H to develop AI-enabled robotic stroke care with Johns Hopkins and Boston University. The project aims to expand access to advanced stroke treatments by integrating robotics, AI, and imaging on Philips' Azurion platform.